Moreover, miR-146b-5p inhibitor can restore the response of MEG3 knockdown (Figure 4(n)), suggesting that in BRCA cells MEG3 can promote SLFN5 expression via sponging the miR-146b-5p. Here, SLFN5 is linked to invasive breast carcinoma.